Fh. Ellis et al., CANCER OF THE ESOPHAGUS AND CARDIA - DOES AGE INFLUENCE TREATMENT SELECTION AND SURGICAL OUTCOMES, Journal of the American College of Surgeons, 187(4), 1998, pp. 345-351
Background: Some physicians believe that an aggressive surgical approa
ch for the management of cancer of the esophagus and cardia is unwise
in elderly patients because of allegedly higher rates of mortality and
morbidity and lower rates of survival than those associated with youn
ger patients. We have long advocated an aggressive surgical approach r
egardless of the patient's age and have reviewed our experience to det
ermine whether age was a factor influencing treatment and outcomes. St
udy Design: From January 1, 1970 to January 1, 1997, 505 patients with
cancer of the esophagus or cardia underwent operations by one surgica
l team using standard surgical techniques. One hundred forty-seven pat
ients (29.1%) were 70 years of age or older and 358 patients (70.9%) w
ere under 70 years of age. Their records and clinicopathologic feature
s were reviewed and compared. Results: The two groups were similar reg
arding the location of tumors. Tumor cell types were similar except fo
r adenocarcinomas in Barrett's esophagus, which were less common in th
e older group (15.6% versus 24%; p = 0.046). Surgical procedures were
similar, as were the rates of resectability and the percentages of RO
resections. The hospital mortality rate was higher in the elderly pati
ents but not significantly so, and the rates of major and minor compli
cations combined were comparable. The differences in postresection pat
hologic staging were not significant. Satisfactory palliation of dysph
agia was comparable between the groups, as were actuarial 5-year survi
val rates (24.1% of the elderly patients versus 22.4% of the younger p
atients). Conclusions: Age should not be a limiting factor in using an
aggressive surgical approach for the management of cancer of the esop
hagus or cardia in patients aged 70 years or older. Such an approach c
an be performed as safely as in younger patients; with comparable fate
s of palliation and survival. (J Am Cell Surg 1998;187: 345-351. (C) 1
998 by the American College of Surgeons).